arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Edwards Lifesciences Corporation

EW Health Care Industrial Specialties
$89.90
Today
as of Sep 4, 16:48 ET
Last 30 days +7.43% Jul 28 → Sep 04
$82.88 $85.78 $88.67 $91.56 $94.46 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$90.21
High
$90.11
Low
$88.40
Volume
$3M
Avg Vol
$4M
Mkt Cap
$50.0B
P/E (TTM)
56.90
Beta
—
52w High
$96.29
52w Low
$72.30
Div Yield
—
Shares Out
$577M

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 1 ● 24 ▼ 0
Sep 2 · 20:15 PR Business Wire neutral
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
Aug 31 · 17:30 Barchart neutral
Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock
Aug 28 · 16:41 Insider Monkey neutral
Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$72
$96
73% of range
Avg surprise (last 2)
+7.4%
Avg reaction (last 2)
-0.8%
0% positive
Latest IV / EM
22%
EM ±3.5% · $90 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.42$1.60$2.77$3.95$5.13 Actual $0.58Actual $0.61Actual $5.13Actual $0.64Est $0.60Actual $0.67Est $0.62Actual $0.50Actual $0.66Actual $0.42 MarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$0$806M$1.6B$2.4B$3.2B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.42 — — — — financials
Tue Mar 31, 2026Mar 2026 $0.66 — — — — financials
Tue Sep 30, 2025Sep 2025 $0.50 — — — — financials
Thu Jul 24, 2025Jun/2025 $0.67 $0.62 +8.1% — -1.4% earnings
Wed Apr 23, 2025Mar/2025 $0.64 $0.60 +6.7% — -0.2% earnings
Mon Sep 30, 2024Sep 2024 $5.13 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.61 — — — — financials
Sun Mar 31, 2024Mar 2024 $0.58 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.74B$1.65B—$1.55B$1.53B$1.41B—$1.35B
Cost of revenue$392M$363M—$345M$344M$302M—$263M
Gross profit$1.35B$1.29B—$1.21B$1.19B$1.11B—$1.09B
Operating income$513M$478M—$307M$411M$395M—$351M
Net income$242M$381M—$291M$333M$356M—$3.07B
EPS (diluted)$0.42$0.66—$0.50$0.56$0.61—$5.13

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$2.91B$2.45B$2.94B$2.69B$3.27B$3.14B$3.05B$3.68B
Inventory$1.13B$1.12B$1.13B$1.14B$1.14B$1.11B$1.09B$1.10B
Total current assets$6.82B$6.23B$6.74B$6.36B$6.58B$6.21B$6.29B$6.73B
Total assets$13.87B$13.32B$13.70B$13.27B$13.49B$13.02B$13.06B$12.97B
Long-term debt$599M$598M$598M$598M$598M$598M$598M$598M
Total liabilities$3.14B$2.99B$3.36B$3.07B$2.88B$2.83B$2.99B$3.36B
Total equity$10.62B$10.33B$10.34B$10.21B$10.61B$10.19B$10.00B$9.61B

Implied volatility — last 90 days

20%38%57%75%93% Jun 07 — IV 33% · EM ±4.5%Jun 08 — IV 35% · EM ±4.7%Jun 09 — IV 40% · EM ±5.0%Jun 10 — IV 60% · EM ±7.1%Jun 11 — IV 48% · EM ±5.3%Jun 12 — IV 53% · EM ±5.4%Jun 15 — IV 53% · EM ±3.8%Jun 16 — IV 59% · EM ±3.5%Jun 17 — IV 94% · EM ±3.9%Jun 19 — IV 28% · EM ±6.3%Jun 22 — IV 29% · EM ±6.1%Jun 23 — IV 28% · EM ±5.8%Jun 24 — IV 27% · EM ±5.4%Jun 25 — IV 26% · EM ±5.1%Jun 26 — IV 26% · EM ±5.1%Jun 29 — IV 25% · EM ±4.4%Jun 30 — IV 27% · EM ±4.6%Jul 01 — IV 25% · EM ±4.1%Jul 02 — IV 22% · EM ±3.6%Jul 03 — IV 23% · EM ±3.6%Jul 06 — IV 27% · EM ±3.8%Jul 07 — IV 28% · EM ±3.7%Jul 08 — IV 31% · EM ±3.8%Jul 09 — IV 40% · EM ±4.7%Jul 10 — IV 20% · EM ±2.2%Jul 13 — IV 33% · EM ±2.8%Jul 14 — IV 30% · EM ±2.2%Jul 15 — IV 38% · EM ±2.2%Jul 16 — IV 52% · EM ±2.2%Jul 20 — IV 38% · EM ±8.9%Jul 21 — IV 37% · EM ±8.6%Jul 22 — IV 39% · EM ±8.9%Jul 23 — IV 44% · EM ±9.8%Jul 24 — IV 32% · EM ±7.2%Jul 27 — IV 33% · EM ±6.9%Jul 28 — IV 30% · EM ±6.1%Jul 29 — IV 29% · EM ±5.8%Jul 30 — IV 28% · EM ±5.5%Jul 31 — IV 30% · EM ±5.8%Aug 03 — IV 29% · EM ±5.1%Aug 04 — IV 29% · EM ±5.0%Aug 05 — IV 26% · EM ±4.4%Aug 06 — IV 30% · EM ±4.8%Aug 07 — IV 29% · EM ±4.6%Aug 10 — IV 28% · EM ±3.9%Aug 11 — IV 31% · EM ±4.0%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 25% · EM ±3.0%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 50% · EM ±4.2%Aug 18 — IV 30% · EM ±2.2%Aug 19 — IV 31% · EM ±1.8%Aug 20 — IV 30% · EM ±1.2%Aug 24 — IV 26% · EM ±5.4%Aug 25 — IV 24% · EM ±4.9%Aug 26 — IV 22% · EM ±4.5%Aug 27 — IV 23% · EM ±4.6%Aug 28 — IV 23% · EM ±4.5%Aug 31 — IV 24% · EM ±4.2%Sep 01 — IV 24% · EM ±4.2%Sep 02 — IV 25% · EM ±4.1%Sep 03 — IV 21% · EM ±3.4%Sep 04 — IV 22% · EM ±3.5%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in